查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468636

2024-2032 年胰臟癌治疗和诊断市场报告（按类型（诊断、治疗）、应用（医院、诊所等）和地区）

Pancreatic Cancer Therapeutics and Diagnostics Market Report by Type (Diagnostics, Treatment), Application (Hospitals, Clinics, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球胰臟癌治疗及诊断市场规模达43亿美元。蓬勃发展的医疗保健行业、胰腺癌患病率的上升以及对杀死胰腺癌细胞的化疗的需求不断增加是推动市场发展的一些关键因素。

胰臟癌治疗和诊断是用于诊断胰臟癌并提供治疗的医疗程序。这些治疗和诊断包括超音波、电脑断层扫描 (CT) 扫描、磁振造影 (MRI) 和正子断层扫描 (PET) 扫描。他们依靠超音波内视镜 (EUS)，使用超音波设备从腹部内部生成胰臟影像。由于胰臟细胞生长失控，它们有助于监测肿瘤的位置。他们协助进行活组织检查，取出一小部分组织样本，以便在显微镜下检查。它们还有助于实验室检查，例如全血细胞计数 (CBC)、胆道阻塞的肝臟酵素测试以及空腹血糖和糖化血红蛋白 (HbA1C) 测试。因此，胰臟癌的治疗和诊断在全球的医院和专科中心得到了应用。

胰臟癌治疗与诊断市场趋势：

目前，由于老年人口增加和群众过度吸烟习惯导致胰臟癌盛行率上升，是支撑市场成长的关键因素之一。除此之外，世界范围内分子生物学、药物和诊断技术的发展也在不断发展。这与蓬勃发展的医疗保健产业目前正在推动市场的成长。此外，透过阻止胰臟癌细胞生长和分裂来杀死胰臟癌细胞的化疗需求不断增加，对市场产生了积极影响。此外，多个国家的管理机构正在大力投资胰臟癌临床试验和脱氧核糖核酸（DNA）修復抑制剂合併化疗。他们也致力于透过批准临床阶段的药物来促进胰腺癌治疗和诊断的发展。除此之外，该行业的主要参与者正在推出一种人源化单株抗体，该抗体可促进抗肿瘤免疫反应，以治疗食道癌和胃食道交界处以及胰腺癌。他们也正在开发和推出基于试剂盒的测试，透过确定 BRCA1 和 BRCA2 变异并评估基因组不稳定性来检测胰臟癌，预计这将有助于未来几年市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球胰臟癌治疗和诊断市场的表现如何，未来几年将如何表现？
  • 全球胰臟癌治疗和诊断市场的驱动因素、限制因素和机会是什么？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的胰臟癌治疗和诊断市场？
  • 依类型划分市场是怎么样的？
  • 胰臟癌治疗和诊断市场中哪种类型最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 胰臟癌治疗和诊断市场中最有吸引力的应用是什么？
  • 全球胰臟癌治疗与诊断市场的竞争结构如何？
  • 谁是全球胰臟癌治疗和诊断市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球胰臟癌治疗与诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 诊断
    • 市场走向
    • 关键环节
      • 影像学
      • 活检
      • 超音波内视镜
      • 其他的
    • 市场预测
  • 治疗
    • 市场走向
    • 关键环节
      • 标靶治疗
      • 化疗
      • 手术
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd.
    • Immunovia AB
    • Novartis AG
    • Pfizer Inc.
Product Code: SR112024A7538

The global pancreatic cancer therapeutics and diagnostics market size reached US$ 4.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.51% during 2024-2032. The burgeoning healthcare industry, rising prevalence of pancreatic cancer, and the escalating demand for chemotherapy to kill pancreatic cancer cells represent some of the key factors driving the market.

Pancreatic cancer therapeutics and diagnostics are medical procedures used to diagnose pancreatic cancer and provide treatment. These therapeutics and diagnostics comprise ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. They rely on an endoscopic ultrasound (EUS) that uses an ultrasound device to produce images of the pancreas from inside the abdomen. They help in monitoring the location of the tumor due to an uncontrollable growth of cells in the pancreas. They assist in performing a biopsy to remove a small sample of tissue for examination under a microscope. They also aid in laboratory investigations, such as a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. As a result, pancreatic cancer therapeutics and diagnostics find applications in hospitals and specialty centers across the globe.

Pancreatic Cancer Therapeutics and Diagnostics Market Trends:

At present, the rising prevalence of pancreatic cancer due to the increasing geriatric population and excessive smoking habits among the masses represents one of the key factors supporting the growth of the market. Besides this, there is an increase in the development of molecular biology, drugs, and diagnostic technology around the world. This, along with the thriving healthcare industry, is currently propelling the growth of the market. In addition, the escalating demand for chemotherapy to kill pancreatic cancer cells by preventing them from growing and dividing is positively influencing the market. Moreover, governing agencies of several countries are extensively investing in pancreatic cancer clinical trial testing and deoxyribonucleic acid (DNA) repair inhibitors combined with chemotherapy. They are also focusing on enhancing the growth of pancreatic cancer therapeutics and diagnostics by approving drugs in the clinical phase. Apart from this, key players operating in the industry are introducing a humanized monoclonal antibody that promotes the anti-tumor immune response for treating esophageal and gastroesophageal junction and pancreatic cancer. They are also developing and introducing kit-based testing to detect pancreatic cancer by determining BRCA1 and BRCA2 variants and assessing genomic instability, which is projected to contribute to the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pancreatic cancer therapeutics and diagnostics market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type and application.

Type Insights:

Diagnostics

Imaging

Biopsy

Endoscopic Ultrasound

Others

Treatment

Targeted Therapies

Chemotherapy

Surgery

Others

The report has provided a detailed breakup and analysis of the pancreatic cancer therapeutics and diagnostics market based on the type. This includes diagnostics (imaging, biopsy, endoscopic ultrasound, and others) and treatment (targeted therapies, chemotherapy, surgery, and others). According to the report, treatment accounted for the largest market share.

Application Insights:

Hospitals

Clinics

Others

A detailed breakup and analysis of the pancreatic cancer therapeutics and diagnostics market based on application has also been provided in the report. This includes hospitals, clinics, and others. According to the report, hospitals represented the leading segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pancreatic cancer therapeutics and diagnostics. Some of the factors driving the North America pancreatic cancer therapeutics and diagnostics market included advancements in diagnostic technologies, emerging therapies and treatment options, increasing healthcare expenditure, and government initiatives and funding.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global pancreatic cancer therapeutics and diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies include AstraZeneca plc, F. Hoffmann-La Roche Ltd., Immunovia AB, Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pancreatic cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global pancreatic cancer therapeutics and diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive pancreatic cancer therapeutics and diagnostics markets?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the pancreatic cancer therapeutics and diagnostics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the pancreatic cancer therapeutics and diagnostics market?
  • What is the competitive structure of the global pancreatic cancer therapeutics and diagnostics market?
  • Who are the key players/companies in the global pancreatic cancer therapeutics and diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pancreatic Cancer Therapeutics and Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Imaging
      • 6.1.2.2 Biopsy
      • 6.1.2.3 Endoscopic Ultrasound
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Treatment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Targeted Therapies
      • 6.2.2.2 Chemotherapy
      • 6.2.2.3 Surgery
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 F. Hoffmann-La Roche Ltd.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Immunovia AB
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Novartis AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Pfizer Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: North America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: North America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: United States: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: United States: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: China: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: China: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: India: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: India: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: France: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: France: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 65: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 67: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
  • Figure 68: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Competitive Structure
  • Table 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Players